Archives fda

by in
Entry Author Date Location
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Sage Preps For Final Test As Epilepsy Drug Holds Up in Small Study 05/14/15 Boston
Gelesis, PureTech’s Weight-Loss Hopeful, Postpones IPO 05/13/15 Boston
Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals 05/13/15 Boston
FDA Panel Backs Vertex’s Two-Drug Combo For Cystic Fibrosis 05/12/15 Boston
Talking Cure? For Cancer Immunotherapy, Still Many Rivers to Cross 05/12/15 National
Alexion Shells Out $8.4B for Synageva In Rare Disease Mega-Deal 05/06/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
NephroGenex Preps $30M Stock Offering to Expand Kidney Drug Trial 05/01/15 Raleigh Durham
Celladon Anticipates Layoffs After Its Gene Therapy Trial Fails 04/27/15 San Diego
Diagnostic-Maker Scanadu Lands $35M As FDA Submission Nears 04/27/15 San Francisco
Wisconsin Roundup: Cellular Dynamics, Baird, Health Apps, & More 04/24/15 Wisconsin
West Coast Biotech Roundup: Juno, Genervon, Tekmira, DNANexus & More 04/23/15 Seattle
Spirox Inhales $18.5M to Advance Nasal Surgery Device 04/21/15 San Francisco
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
HAP Innovations Tackles Missed Meds with Automated Dispenser 04/14/15 Raleigh Durham
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug 04/09/15 New York
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
Horizon Pays $1.1 Billion for Hyperion’s Rare Disease Drugs 03/30/15 San Francisco
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill 03/26/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Somna Makes Case for Simple Device Before Drugs, Surgery for Reflux 03/19/15 Wisconsin
Ginkgo Bioworks Grabs $9M Series A For Building Organisms 03/18/15 Boston
Page 2 of 45 « previous page · next page »